Baird Medical Investment Holdings (BDMD) Long-Term Deferred Tax (2023 - 2025)
Baird Medical Investment Holdings' (BDMD) quarterly Long-Term Deferred Tax came in at $762289.0 in Q4 2025, up 6.69% year-on-year from $714461.0 in Q4 2024, and up 8.82% on a QoQ basis from $700524.0 in Q2 2025.
Baird Medical Investment Holdings (BDMD) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has 3 years of Long-Term Deferred Tax data on file, last reported at $762289.0 in Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax rose 6.69% year-over-year to $762289.0 in Q4 2025; TTM through Dec 2025 was $762289.0, a 6.69% increase from a year earlier, with the FY2025 full-year figure at $762289.0, up 6.69% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $762289.0, up from $700524.0 in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for BDMD reached as high as $814372.0 in Q4 2023 and fell as low as $700524.0 in Q2 2025.
- Historically, Long-Term Deferred Tax has averaged $747911.5 across 3 years, with a median of $738375.0 in 2024.
- Across the five-year window, Long-Term Deferred Tax dropped 12.27% in 2024 and advanced 6.69% in 2025, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $814372.0 in 2023, then retreated by 12.27% to $714461.0 in 2024, then grew by 6.69% to $762289.0 in 2025.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $762289.0 in Q4 2025, $700524.0 in Q2 2025, and $714461.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Baird Medical Investment Holdings | 30.57 Mn | 30.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 762,289.00 |
| Jun 30, 2025 | 700,524.00 |
| Dec 31, 2024 | 714,461.00 |
| Dec 31, 2023 | 814,372.00 |